Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBC and FeNO Markers in Children With Asthma
NCT00961155Phase 2Unknown
- Sponsor
- Medical University of Lodz
- Start
- Aug 2009
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ciclesonide, montelukast and formoterol in asthma (4 arms), sponsored by Medical University of Lodz. Primary endpoints: Measurement of IL-4, 5, 6, 8, 16, MIG, TNF-alpha, MCP-1 in EBC and Measurement of ECP, eosinophil blood count, cotinine and total IgE in blood. Status: unknown.
02
Drugs
ciclesonidemontelukastformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00961155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00961155.